ArticleMolecular therapy. Methods & clinical development2018

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.

Junhui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.